Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies
HLA antibodies (HLA ab) in transplant candidates have been associated with poor outcome. However, clinical relevance of noncytotoxic antibodies after heart transplant (HT) is controversial. By using a Luminex-based HLA screening, we retested pretransplant sera from HT recipients testing negative for...
Main Authors: | Luciano Potena, Andrea Bontadini, Sandra Iannelli, Fiorenza Fruet, Ornella Leone, Francesco Barberini, Laura Borgese, Valentina Manfredini, Marco Masetti, Gaia Magnani, Francesco Fallani, Francesco Grigioni, Angelo Branzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2013/519680 |
Similar Items
-
Noncytotoxic silver nanoparticles as a new antimicrobial strategy
by: Bartosz Skóra, et al.
Published: (2021-06-01) -
Noncytotoxic Pyrrolobenzodiazepine–Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis
by: Pietro Picconi, et al.
Published: (2019-12-01) -
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
by: Alessandra Zecca, et al.
Published: (2021-03-01) -
Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
by: Michiel G. H. Betjes, et al.
Published: (2020-01-01) -
Different Impact of Pretransplant Anti-HLA Antibodies Detected by Luminex in Highly Sensitized Renal Transplanted Patients
by: Isabel Pérez-Flores, et al.
Published: (2013-01-01)